Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Clinical trial NCT05132504 · RECRUITING
Trial details
- NCT number
- NCT05132504
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-31
- Primary completion
- 2027-05-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.